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Summary
 
Enteropathogenic 
 
Escherichia coli
 
 (EPEC) belongs to a family of related bacterial pathogens, in-
cluding enterohemorrhagic 
 
Escherichia coli
 
 (EHEC) O157:H7 and other human and animal di-
arrheagenic pathogens that form attaching and effacing (A/E) lesions on host epithelial surfaces.
Bacterial secreted Esp proteins and a type III secretion system are conserved among these
pathogens and trigger host cell signal transduction pathways and cytoskeletal rearrangements,
and mediate intimate bacterial adherence to epithelial cell surfaces in vitro. However, their role
in pathogenesis is still unclear. To investigate the role of Esp proteins in disease, mutations in
 
espA
 
 and 
 
espB
 
 were constructed in rabbit EPEC serotype O103 and infection characteristics
were compared to that of the wild-type strain using histology, scanning and transmission elec-
tron microscopy, and confocal laser scanning microscopy in a weaned rabbit infection model.
The virulence of EspA and EspB mutant strains was severely attenuated. Additionally, neither
mutant strain formed A/E lesions, nor did either one cause cytoskeletal actin rearrangements
beneath the attached bacteria in the rabbit intestine. Collectively, this study shows for the first
time that the type III secreted proteins EspA and EspB are needed to form A/E lesions in vivo
and are indeed virulence factors. It also confirms the role of A/E lesions in disease processes. 
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A
 
family of enteropathogenic 
 
Escherichia coli
 
 (EPEC)
 
1
 
 causes
diarrhea in humans and animals (1), yet the mechanism
by which they cause disease in vivo has not been defined.
These pathogens cause a characteristic histopathological le-
sion termed an attaching/effacing (A/E) lesion (2), although
the contribution of this lesion to disease has not been de-
fined. Enterohemorrhagic 
 
Escherichia coli
 
 (EHEC) O157:H7
also causes this lesion (3–5). Several genes are involved in
formation of the A/E lesion in tissue culture cells, includ-
ing 
 
eae
 
 (which encodes intimin, an adhesin) and 
 
espB
 
 (which
encodes a secreted protein), and these genes are conserved
in EPEC, EHEC, and rabbit EPEC strains (6, 7).
The A/E lesion is defined by the intimate attachment
between bacteria and the epithelial surface, and the efface-
ment (disappearance) of host cell microvilli. Alteration of
cytoskeletal components beneath adherent bacteria results
in formation of a pedestal-like structure that can extend to
a pseudopod. In vitro (tissue culture), the A/E lesion is
mediated by bacteria–host cell interactions, including trig-
gering of host signal transduction pathways (8–10). Initial
localized adherence to epithelial cells is mediated by a plas-
mid-encoding, bundle-forming pilus (BFP) (11–15), fol-
lowed by the insertion of translocated intimin receptor
(Tir), a bacterial protein, into the host plasma membrane
(10). Tir (10), formerly Hp90 (16), is delivered to tissue
culture cells, and requires the secreted proteins EspA and
EspB for its translocation. Tir has at least three possible
functions that have been identified (10). Tir is translocated
into the epithelial cell membrane and serves as a cell surface
 
1
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receptor for intimin. The second function of Tir is to nu-
cleate actin after intimin binding. The third function is to
transmit additional signals to host cells once Tir–intimin in-
teraction occurs. These events trigger tyrosine phosphory-
lation of phospholipase C
 
g
 
 (17) and other host proteins,
and the resulting signals follow Tir phosphorylation and
other early signaling events.
EPEC A/E lesions require products of a 35-kb locus
termed the LEE (locus of enterocyte effacement; 18) that
includes the 
 
esc
 
 cluster, 
 
tir
 
, 
 
eae
 
, 
 
espA
 
, 
 
espD
 
, and 
 
espB
 
(formerly 
 
eaeB
 
). The 
 
esc
 
 cluster encodes a type III secretion
system responsible for secretion of Esp proteins (19). 
 
tir
 
 and
 
eae
 
 encode Tir (10) and intimin (20), which are required
for intimate attachment in vitro. At least three secreted
proteins, EspA (21), EspB (22) and EspD (23), encoded by
 
espA
 
, 
 
espB
 
, and 
 
espD
 
, are secreted via the type III secretion
pathway. These secreted proteins are essential for triggering
of host signal transduction pathways in tissue culture cells.
However, it is not known if these processes, and thus these
secreted proteins, are needed for virulence in vivo.
To investigate the role of EspA and EspB in EPEC
pathogenesis, we constructed mutant strains in 
 
E. coli
 
 sero-
type O103. In Europe, serotype O103 is the most common
rabbit EPEC (REPEC) strain, causing heavy diarrhea in
weaned rabbits, and its rhamnose fermentation negative
phenotype is linked to high virulence (24–26). 
 
E. coli
 
 O103
also causes histopathological features similar to that caused
by EPEC in the intestine, including A/E lesions on the in-
testinal mucosa (27, 28). Recently, the 
 
E. coli
 
 O103 LEE
region has been studied (29). However, the role of the type
III secreted proteins EspA and EspB in virulence is still un-
clear, as is the role of the A/E lesion in disease for this fam-
ily of pathogens. Here we report characterization of disease
in rabbits infected with strains that are defective for EspA
and EspB using a rabbit infection model, and show that
these two secreted proteins and the resulting A/E lesions
formed are essential for pathogenesis.
 
Materials and Methods
 
Bacterial Strains, Plasmids, Cell Culture and Media. E. coli
 
 sero-
type O103 85/150 strain causes heavy diarrhea in weaned rabbits
 
and was provided by Dr. Johan E. Peeters (National Institute of
Veterinary Research, Brussels, Belgium). The phenotypes and ge-
notypes of this strain and other bacteria used in this study are
listed in Table 1. Plasmids pAA23
 
D
 
 and pAABxb
 
D
 
 (7) are deriva-
tives of a positive suicide vector pCVD442 that contains 
 
sacB
 
, 
 
bla
 
,
and a 
 
pir
 
-dependent R6K replicon (30). HeLa cells were main-
tained and assayed in MEM containing 10% (vol/vol) fetal calf
sera at 37
 
8
 
C in a 5% CO
 
2
 
 incubator. For infection, REPEC and
mutant strains were grown in Luria-Bertani (LB) broth overnight
at 37
 
8
 
C without shaking.
 
Construction of Nalidixic Acid Resistant Derivative of REPEC
O103.
 
Strain 85/150 was inoculated in 25 ml LB media and in-
cubated overnight. After centrifugation, bacteria were plated on
LB agar containing 30 
 
m
 
g/ml nalidixic acid. A resulting nalidixic
acid resistant strain was used for further experiments and desig-
nated as REPEC O103.
 
Construction of Nonpolar Stop Codon Mutations in REPEC O103
espA and espB.
 
Plasmid pAA23
 
D
 
 and pAABxb
 
D
 
 are positive
suicide vectors, and were designed for construction of nonpolar
mutations in 
 
espA
 
 and 
 
espB
 
, respectively (7). Plasmid pAA23
 
D
 
contains RDEC-1 
 
espA
 
 including a stop codon and a BglII site
235 bp downstream from the 
 
espA
 
 start codon. This plasmid
was introduced into 
 
E. coli
 
 SM10
 
l
 
pir
 
 (31) and was transconju-
gated into REPEC O103 as described elsewhere (30). Plasmid
pAABxb
 
D
 
 (7) contained a stop codon in addition to a 250-bp de-
letion, starting 154 bp downstream of the 
 
espB
 
 start codon. This
plasmid was transformed into 
 
E. coli
 
 SM10
 
l
 
pir
 
 and transconju-
gated into REPEC O103. Both mutant strains were selected by
resistance to sucrose and nalidixic acid and sensitivity to ampicillin.
 
Preparation of Secreted Proteins.
 
Bacterial overnight cultures were
diluted 1:100 into DMEM and incubated for 6.5 h in a 5% CO
 
2
 
incubator. Bacteria were removed by centrifugation (18,000 
 
g
 
 for
10 min) and the supernatant was precipitated by addition of 10%
ice-cold TCA, and incubated on ice for 1 h. After centrifugation,
the pellets were resuspended in Laemmli sample buffer and ana-
lyzed by 12% SDS-PAGE (32).
 
Immunofluorescence Microscopy.
 
HeLa cells (10
 
5
 
) were inocu-
lated and grown overnight on coverslips, then infected with
REPEC O103 or its mutant strains for 3 h. Cells were washed
three times with PBS and fixed with 3.0% PFA in PBS (pH 7.2)
for 30 min at room temperature, then washed twice with PBS.
The fixed cells were permeabilized with 20 
 
m
 
l 0.1% Triton X-100
in PBS in the presence of phalloidin–Texas Red (TxR) (Molecu-
lar Probes, Eugene, OR) to stain filamentous actin, and antiphos-
photyrosine antibodies, clone 4G10 (Upstate Biotechnology,
Lake Placid, NY). FITC-conjugated anti–mouse IgG and IgM
 
Table 1.
 
Strains Used in this Study
 
Strain Relevant characteristics Comments Reference
85/150 Rabbit EPEC Prototypic O103:K
 
2
 
:H2 strain, rhamnose negative 24
RDEC-1 Rabbit EPEC Prototypic O15:K
 
2
 
:H
 
2
 
 strain 43
E2348/69 Human EPEC Prototypic O127:H6 EPEC strain 44
REPEC O103 Rabbit EPEC Nalidixic acid resistant strain derived from 85/150 This study
AAF004 REPEC O103 (EspA
 
2
 
) Nonpolar mutation in REPEC O103 
 
espA
 
This study
AAF005 REPEC O103 (EspB
 
2
 
) Nonpolar mutation in REPEC O103 
 
espB
 
This study
SM10
 
l
 
pir Thi thr leu tonA lacY supE
 
Donor strain for constructing REPEC 31
 
resA
 
::RP4-2-Tc::Mu Km Mutant strains 
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(ICN Pharmaceuticals Inc., Costa Mesa, CA) was used as the sec-
ondary antibody for antiphosphotyrosine. Stained samples were
visualized and photographed as described elsewhere (33).
 
Rabbit Infection.
 
Overnight standing bacterial cultures were
collected by centrifugation and resuspended in 2 ml PBS. Bacteria
(7 
 
3
 
 10
 
8
 
 in 2 ml PBS) were given to New Zealand white rabbits
(female, 461–636 g, 28–36-d-old) using orogastric tubes, and
bacteria inside the orogastric tubes were flushed with an addi-
tional 2 ml PBS wash.
 
Tissue Preparation and Histological Procedure.
 
After 1–4 d infec-
tion, tissues from ileum, Peyer’s patches, cecum, and proximal
colon were excised immediately after sacrifice by intravenous in-
jection of ketamine and overdosing of sodium pentobarbital in
accordance to the guidelines of the Canadian Council of Animal
Care and the University of British Columbia. For light micros-
copy, intestinal tissues were fixed in 10% neutral buffered forma-
lin and processed for paraffin embedding. Serial 4-
 
m
 
m-thick sec-
tions were cut onto glass slides and stained with hematoxylin and
eosin, and examined and photographed using a light microscope
(AH-2; Olympus America Inc., Melville, NY). For scanning
electron microscopy (SEM) and transmission electron microscopy
(TEM), tissues were washed in PBS and prefixed in 2.5% glu-
taraldehyde, then rinsed in 0.1 M cacodylate buffer. After postfix-
ation in 1% osmium tetroxide, tissues were stained in 2% uranyl
acetate, then dehydrated in graded ethanols. SEM sections were
critical point-dried using liquid carbon dioxide and coated with
gold. The resulting sections were examined with an SEM (Ste-
reoscan 250 MK III; Leica Inc., Deerfield, IL). TEM sections
were further dehydrated in graded ethanols and propylene oxide,
then embedded in Spurr’s resin. After polymerization, ultrathin
sections (90 nm) were stained with uranyl acetate and lead citrate
and examined with a TEM (EM 10A/B; Carl Zeiss Inc., Thorn-
wood, NY).
 
Preparation of Thick Cryosection of Intestinal Tissues.
 
Intestinal tis-
sues were fixed with 4% PFA in PBS (pH 7.2) for 2 h at room
temperature, washed twice with PBS, then incubated in 20%
sucrose in PBS overnight at 4
 
8
 
C for cryoprotection. Tissue sam-
ples were embedded in OCT Tissuetek (Miles Laboratories Inc.,
Elkhart, IN), then frozen in cold 3-methyl-butane (
 
2
 
50 to
 
2
 
60
 
8
 
C). The frozen tissues were cut at 20 
 
m
 
m sections on a cryo-
stat, then kept in PBS at 4
 
8
 
C.
 
Immunochemistry of Thick Cryosections.
 
Sections were incu-
bated in 10% normal goat serum in PBS for 10 min, then perme-
abilized with 100 
 
m
 
l permeabilization buffer (0.2% saponin, 10%
normal goat serum in PBS) in the presence of mouse antisera
against REPEC O103 (1:200) overnight at 4
 
8
 
C. Sections were
washed three times in PBS, then incubated in 0.2% saponin and
10% normal goat serum in PBS in the presence of phalloidin-
TxR (1:400; Molecular Probes) and FITC-conjugated anti–
mouse IgG and IgM (ICN Pharmaceuticals Inc.) as the secondary
antibody for anti-REPEC O103 antibody. Tissue samples were
washed twice in PBS, then mounted on coverslips and visualized
as described elsewhere (34). In brief, stained sections were visual-
ized by a confocal laser scanning microscope (MRC-600; Bio-
Rad Labs., Hercules, CA) under control of COMOS software
(Bio-Rad Labs.) The resulting scanned images were analyzed by a
public domain image processing and analysis program, NIH Im-
age (National Institutes of Health, Bethesda, MD), and processed
images were exported to Adobe Photoshop (Adobe Systems Inc.,
San Jose, CA) to assign different fluorophore images into individ-
ual RGB channels.
 
Nucleotide Sequence Accession Numbers.
 
Nucleotide sequence data
used in this study are available from the EMBL/GenBank/DDBJ
 
under the following accession numbers: RDEC-1 
 
eae, U60002;
REPEC O103 84/110/1 eae, U59502; and REPEC O103 85/150
espB, AF059713.
Results
Construction of Nonpolar Mutations in espA and espB. To
construct mutations in espA and espB, a nalidixic acid resis-
tant strain of E. coli serotype O103 85/150 (REPEC O103)
was established, then nonpolar mutations were constructed
by inserting a stop codon into these genes as described in
Materials and Methods. To confirm mutations in espA and
espB, chromosomal DNA was prepared from each mutant
strain and PCR analysis was performed with two sets of
primers encompassing espA or espB. The resulting PCR
products were digested with BglII to confirm the presence
of this engineered restriction site (data not shown). The
mutant strains containing the stop codon in espA and espB
were designated as AAF004 (EspA2) and AAF005 (EspB2),
respectively.
Protein Secretion Profile of REPEC O103 and Its Mutant
Strains in Tissue Culture Media. We have already shown
that another rabbit EPEC strain, RDEC-1, secretes EspA
and EspB into culture media (7). The secreted protein pro-
file of REPEC O103 was quite similar to that of RDEC-1,
and EspA and EspB in both rabbit EPEC strains migrated
faster compared to those from the human EPEC strain (Fig.
1 A). Interestingly, EspC (110 kD) in both rabbit EPEC
strains was not detectable using Coomassie blue staining.
However, this protein is not involved in EPEC triggering
of host signal transduction pathways and intimate adher-
ence in vitro (35). In contrast, AAF004 (EspA2) and
AAF005 (EspB2) lacked bands corresponding to EspA and
EspB. Although we constructed both mutant strains by in-
serting a stop codon that should not affect downstream
gene expression, the amounts of other secreted proteins
were less compared to the wild-type O103 strain (Fig. 1 B).
It is possible that lack of an Esp protein might affect the se-
cretion of other Esp proteins by altering transcriptional,
posttranslational events, and/or Esp–Esp protein interac-
tion. However, these effects might be common features of
type III secretion in EPEC, because the reduced amount of
secreted proteins were also found in the EspB (36) and
EspD (23) mutant strains in EPEC O127. The reduced
amount of other secreted proteins in EspA and EspB mu-
tant strains might contribute to changes in the virulence
phenotypes.
Figure 1. Secreted protein pro-
files of REPEC O103, RDEC-1,
EPEC (A), and REPEC O103 mu-
tant strains (B). Bacteria were grown
in DMEM and the secreted proteins
were precipitated by addition of 10%
TCA, and then analyzed by 12%
SDS-PAGE stained with Coomassie
blue. Strains: REPEC O103, O103;
AAF004 (EspA2),  DespA; AAF005
(EspB2), DespB.1910 Secreted Enteropathogenic Escherichia coli Virulence Factors
EspA and EspB Proteins Are Involved in Cytoskeletal Rear-
rangements in HeLa cells. EPEC EspA and EspB are in-
volved in accumulation of cytoskeletal actin and tyrosine-
phosphorylated proteins beneath attached bacteria in tissue
culture cells (21, 37). To confirm the role of REPEC
O103 EspA and EspB in triggering these events in HeLa
cells, cytoskeletal actin and tyrosine phosphorylated pro-
teins were stained with phalloidin-TxR and FITC-labeled
antiphosphotyrosine (Fig. 2). Unlike EPEC, REPEC O103
did not form microcolonies, but adhered diffusely on cell
surfaces. This strain also accumulated cytoskeletal actin and
tyrosine phosphorylated proteins beneath the attached bac-
teria. These accumulation patterns, including horseshoe-
shaped structures, are similar to those caused by EPEC. In
contrast, AAF004 (EspA2) and AAF005 (EspB2) strains did
not accumulate cytoskeletal actin or tyrosine-phosphory-
lated proteins beneath the attached bacteria. These results
suggest that EspA and EspB proteins in both EPEC and
REPEC O103 are necessary for triggering of cytoskeletal
rearrangements in HeLa cells.
Virulence of EspA2 and EspB2 Strains in Rabbits. To de-
termine if EspA and EspB are involved in disease, rabbits
were infected with REPEC O103 and the mutant strains
via an orogastric route, and the virulence of these mutant
strains was compared to that of the wild-type strain. Rab-
bits (n 5 5) infected with REPEC O103 (7 3 108) suffered
weight loss and one rabbit died with watery diarrhea 7 d af-
ter infection. Rabbits that survived (n 5 4) showed signifi-
cant weight loss compared to rabbits given PBS (n 5 3;
Fig. 3 A). In contrast, rabbits given AAF004 (EspA2, n 5
5) and AAF005 (EspB2, n 5 4) did not show any diarrhea-
genic symptoms or weight loss (Fig. 3, B and C). These re-
sults clearly show that EspA and EspB are involved in these
disease processes.
Histological Analysis of Intestinal Tissues from Rabbits Infected
with REPEC O103 and Mutant Strains. After 72 h of in-
fection, ileal sections were obtained from rabbits infected
with REPEC O103, AAF004 (EspA2), and AAF005 (EspB2),
and stained with hematoxylin and eosin. Only animals in-
fected with REPEC O103 showed histological evidence of
blunting of intestinal villi, necrosis of mucosal epithelial
cells and sloughing, and increased inflammation consisting
of a mixture of polymorphonuclear leukocytes, lympho-
cytes, and plasma cells (Fig. 4 A). In contrast, animals in-
fected with AAF004 (EspA2) and AAF005 (EspB2) did not
have altered villous architecture, nor increase inflammatory
cell infiltrates in the lamina propria or muscularis layers
(Fig. 4, B and C), much like the uninfected controls (Fig. 4
D). Furthermore, increased injury and inflammation were
also observed in Peyer’s patches when rabbits were infected
with REPEC O103, but not with EspA and EspB mutant
strains (data not shown). These results indicate that EspA
and EspB are involved in inflammation and disruption of
the mucosal epithelial surface.
Figure 2. Accumulation of cytoskeletal actin and tyrosine-phosphory-
lated proteins beneath bacteria in cultured epithelial cells. HeLa cells (105)
were infected for 3 h with REPEC O103 or isogenic mutant strains. In-
fected HeLa cells were fixed by the addition of paraformaldehyde, then
phalloidin-TxR and antiphosphotyrosine antibodies (aPY) were used for
detection of colocalization of actin and tyrosine-phosphorylated proteins
by immunofluorescence microscopy. Strains: REPEC O103, O103;
AAF004 (EspA2), DespA; AAF005 (EspB2), DespB.
Figure 3. Growth curves of rabbits that survived infection with REPEC O103 (A) or those infected with AAF004 (B), and AAF005 (C). Bacteria
(7 3 108) were inoculated via the orogastric route and weights were measured daily. Values represent the average rabbit weight 6 SD. Strains and control
are indicated as follows: REPEC O103, black square; AAF004 (EspA2), white circle; AAF005 (EspB2), black triangle; PBS inoculation, gray circle.1911 Abe et al.
Adherence of REPEC O103 and Mutant Strains to Intestinal
Villi. To analyze how EspA and EspB contribute to ad-
herence to the mucosal surface, rabbits were killed 1–4 d
after infection, and intestinal sections, including ileum,
Peyer’s patches, cecum, and proximal colon, were visual-
ized by SEM. REPEC O103 was detected in all intestinal
tissues (summarized in Table 2). In the ileum, bacteria were
detected 24 h after infection, and showed diffuse adherence
48–72 h after infection (Fig. 5 A). The bacteria were some-
times aggregated and clumped on top of each other, and
embedded into the ileal surface (Fig. 5 B). At higher mag-
nifications, cup-like structures were also observed on the
epithelial surface, presumably caused by detached bacteria
(Fig. 5 C). In Peyer’s patches, REPEC O103 appeared to
adhere preferentially to the domed villi (follicle associated
epithelium) 48 h after infection, but bacteria were also ob-
served in normal villi of Peyer’s patches 72 h after infection
(data not shown). In the proximal colon, REPEC O103
showed a similar adherence pattern, but bacteria appear to
bind to mucus rather than the epithelial surface. Although
we could detect bacteria in the cecum, bacterial adherence
was less than in other intestinal sections.
Although the adherence of AAF004 (EspA2) and
AAF005 (EspB2) was somewhat delayed compared to that
of wild-type, both strains adhered to the ileum (Fig. 5, D
and E), Peyer’s patches, and proximal colon 72–96 h after
infection (summarized in Table 2). However, we could not
detect embedded bacteria as shown in Fig. 5 B, nor forma-
tion of cup-like structures on epithelial surfaces as in Fig. 5
C. These results suggest that formation of embedded and
cup-like structures require EspA and EspB, although the
initial (nonintimate) adherence of both AAF004 (EspA2)
and AAF005 (EspB2) is similar to that of the parental strain.
EspA and EspB Are Required for A/E Lesions In Vivo.
To examine bacterial adherence in more detail, rabbit in-
testinal samples were analyzed using TEM. The results
showed that REPEC O103 caused typical A/E lesions in
vivo and intimately associated with the ileal surface (Fig. 6
A). Elongated and swollen microvilli and microbodies were
Figure 4. Hematoxylin and eosin–stained ileal sections of rabbits in-
fected with REPEC O103 (A), AAF004 (B), AAF005 (C), and PBS inoc-
ulation (D). Note the extensive villous blunting, epithelial cell necrosis
and sloughing, and inflammation within the lamina propria of the wild-
type infected tissue (A). In contrast, villous architecture and extent of in-
flammation within the lamina propria infected with AAF004 (EspA2) or
AAF005 (EspB2) are similar to those of control animals that were inocu-
lated PBS. Bar, 100 mm.
Table 2. Phenotypes of REPEC O103 and Mutant Strains
Strain
Adherence*
A/E lesions and
cup-like
structures
IL PP CE PC IL PP CE PC
REPEC O103 111 111 1 111 1 1 – 1
AAF004 (EspA2) 11 11 1 11 –– – –
AAF005 (EspB2) 11 11 1 11 –– – –
*Degree of adherent efficiency was assigned as follows: 1, few adherent
bacteria; 11, diffuse adherence; 111, intimate adherence.
Tissue samples: IL, ileum; PP, Peyer’s patches; CE, cecum; PC, proxi-
mal colon.
Figure 5. Scanning electron mi-
crographs of the ileal villi infected
with REPEC O103 (A–C),
AAF004 (D), and AAF005 (E).
REPEC O103, AAF004 (EspA2),
and AAF005 (EspB2) adhered to
the villi, and the adherence pattern
is similar between wild-type and
mutant strains. However, embed-
ded bacteria as indicated by an ar-
row (B) and cup-like structures (C) were observed only in rabbits infected
with REPEC O103. Ileal sections were taken 72 h (for REPEC O103
and AAF005) and 96 h (for AAF004) after infection. Bar, 4 mm.1912 Secreted Enteropathogenic Escherichia coli Virulence Factors
observed closely associated with adherent bacteria. The
bacteria rested on cups or pedestals, sometimes oriented
perpendicularly or invaginated into host epithelial mem-
branes. The glycocalyx and microvilli were completely dis-
rupted beneath attached bacteria. Indicative of progressive
intracellular damage, the enterocytes showed a pale vacu-
olated watery cytoplasm and disappearance or dysmorphy
of mitochondria, ribosomes, and endoplasmatic reticulum,
as well as pale nuclei, with the enterocytes often being ex-
truded into the lumen. These typical A/E lesions were
found in the ileum, Peyer’s patches, and proximal colon,
but not in the cecum (summarized in Table 2). In contrast,
when rabbits were infected with AAF004 (EspA2) and
AAF005 (EspB2), no A/E lesions were detected in ileal tis-
sue (Fig. 6, B and C) or other intestinal sections examined.
The microvilli beneath these bacteria still exhibited its nor-
mal brush border, and no sign of intracellular damage could
be found. These results suggest that EspA and EspB are
needed to trigger A/E lesions and cell damage in vivo.
We have already shown that EspA and EspB were
needed for efficient delivery of Tir, which was required for
intimate adherence to HeLa cells (10). In this study, both
mutant strains did not adhere intimately and did not make
A/E lesions, presumably due to the inability to deliver Tir
to the host membrane. However, these strains still adhered
at a distance above the ileal surface. An adhesive factor,
AF/R2, was previously identified in REPEC O103 and is
needed for nonintimate adherence (38). Therefore, the ini-
tial (nonintimate) adherence at a distance from ileal surfaces
(Fig. 6, B and C) is probably mediated by AF/R2 or an-
other adhesin. Indeed, adherent patterns in EspA and EspB
mutant strains were quite similar to that of the EPEC EspB
mutant strain in Hep-2 cells (22), although EPEC initial ad-
herence to epithelial cells is mediated by bundle-forming pilus.
EspA and EspB Are Required for Cytoskeletal Rearrange-
ments and Diarrhea. The role of cytoskeletal actin rear-
rangements mediated by EPEC infection in vivo is still un-
clear. To determine if cytoskeletal rearrangements also occur
in vivo and are similar to those seen with tissue culture
cells, cytoskeletal actin of epithelial surfaces were analyzed
by confocal laser scanning microscopy (CLSM) using anti-
O103 antibody and phalloidin-TxR, which specifically
stains filamentous actin. We selected sections from ileum
and Peyer’s patches at 72 h after infection for examination.
REPEC O103 adhered well to Peyer’s patches (Fig. 7)
confirming the SEM and TEM results. When tissue was
stained with phalloidin-TxR, we found that the cytoskele-
tal actin was highly reorganized and formed cup-like struc-
tures beneath attached bacteria (Fig. 7). Bacterial coloniza-
tion occurred in the ileum and Peyer’s patches when rabbits
were infected with AAF004 (EspA2) and AAF005 (EspB2).
However, both mutant strains never triggered cytoskeletal
rearrangements beneath the attached bacteria (Fig. 7).
These results indicate that EspA and EspB are involved in
triggering of cytoskeletal actin rearrangement and cup-like
structures in vivo, processes that are needed for disease.
Discussion
We show here that formation of A/E lesions mediated
by the type III secreted proteins, EspA and EspB, is in-
Figure 6. Transmission micrographs of the ileal villi infected with
REPEC O103 (A), AAF004 (B), and AAF005 (C). The REPEC O103
are intimately associated with the ileal villi and form pedestal-like struc-
tures, which are indicated by arrows. Microbodies and elongated and
swollen microvilli were also observed. In contrast, AAF004 (EspA2) and
AAF005 (EspB2) do not cause A/E lesions, and intracellular damage was
not seen. All ileal sections were taken 96 h after infection. Original mag-
nification, 36,300.1913 Abe et al.
volved in virulence using histology, SEM, and TEM. Fur-
thermore, thick tissue sections prepared from infected in-
testinal organs were analyzed by CLSM, revealing for the
first time that the A/E lesion is formed by extensive cy-
toskeletal actin rearrangement in vivo.
Due to host tropism of human EPEC and their limita-
tion to human in vivo studies, we used a natural rabbit in-
fection model, EPEC serotype O103, to study disease
events. Human EPEC serotype O127 normally infects only
young children and does not infect animals. We have pre-
Figure 7. Confocal laser scanning micrographs of Peyer’s patches infected with REPEC O103, AAF004, and AAF005. Peyer’s patches were taken 72 h
after infection and cryosections (20-mm-thick) were stained with phalloidin-TxR (red for overlay) and anti-O103 antibody (green for overlay). REPEC
O103 adhered and colonized to the Peyer’s patches, cytoskeletal actin beneath the attached bacteria was rearranged, and cup-like structures were also ob-
served. In contrast, a small number of EspA and EspB mutant strains were observed in villi crypts, but no actin rearrangements occurred. Strains: REPEC
O103, O103; AAF004 (EspA2), DespA; AAF005 (EspB2), DespB; PBS inoculation, Control.1914 Secreted Enteropathogenic Escherichia coli Virulence Factors
viously shown that maximal expression of EPEC Esp pro-
teins occurs at 378C, and their expression is reduced at
398C, which corresponds to rabbit body temperature (7).
The adaptation to human body temperature is one possible
explanation of the narrow host range of EPEC. Although
an EPEC infection study was carried out using human
adult volunteers (39), this does not reflect a natural infec-
tion as adults were used and a high infection inoculum was
required. In contrast, the advantages of using REPEC
O103 are that this pathogen naturally infects weaned rab-
bits, forms the A/E lesion, and has a conserved LEE locus
similar to EPEC O127. Thus the natural rabbit infection
model using REPEC O103 is a useful model of human
EPEC infections.
REPEC O103 secreted at least three proteins, EspA,
EspB, and EspD, and its secretion profile was similar to that
of another rabbit EPEC strain, RDEC-1 serotype O15. In-
deed, DNA sequencing alignment analysis showed that the
open reading frame encoding intimin (eae, 2820 bp) in
REPEC O103 84/110/1 strain (24) is very similar to that
of RDEC-1 (99.8% identity) with two nucleotide changes
at positions 2608 bp (C to T) and 2709 bp (C to T). Fur-
thermore, we have partially sequenced REPEC O103 espB
and found it was identical to RDEC-1 espB from positions
22–924 bp, corresponding to 95.5% of the espB gene.
These similarities indicate that other genes located in the
REPEC LEE locus are highly conserved between serotype
O103 and O15. We have previously established RDEC-1
EspA and EspB mutant strains using suicide vectors
pAA23D and pAABxbD, which were originally constructed
using RDEC-1 espA and espB (7). As expected, both vec-
tors also functioned in REPEC O103 due to their se-
quence similarity. However, we were unable to produce
any disease in rabbits infected with high doses of RDEC-1,
and thus we switched to infection studies using REPEC
O103 and its espA and espB nonpolar mutant strains.
REPEC O103 causes actin nucleation beneath the at-
tached bacteria and forms horseshoe-like structures on
HeLa cells, and this accumulation requires EspA and EspB.
In contrast to our results, De Rycke et al. (29) have re-
ported that REPEC O103 B10 strain does not accumulate
actin beneath adherent bacteria 4 h after infection. Instead
of actin accumulation, B10 induces a cytopathic effect
(CPE) by causing vinculin accumulation, and the accumu-
lation of vinculin forms a rod-shaped pattern 48 h after in-
fection. Although human EPEC E2348/69 serotype O127
does not show a CPE, this CPE in B10 strains is dependent
on the type III secretion system (29). De Rycke et al. sug-
gested that the lack of EPEC-like actin accumulation is due
to the diffuse adherence mediated by an AF/R2 (38, 40).
However, REPEC O103 used in this study showed the
same diffuse adherence pattern, and the secretion profiles of
REPEC O103 and B10 appear similar. These results indi-
cate that O103 strains might differ in causing cytoskeletal
rearrangements and that the REPEC O103 strain used in
this study may be more similar to the human EPEC strain.
Studies with adult human volunteers indicate that EPEC
intimin mutants are decreased for virulence (39). Diarrhea
still developed in 4 out of 11 volunteers who ingested the
intimin mutant strain, indicating that other virulence fac-
tors are also involved in EPEC pathogenesis. In this study,
the virulence of EspA and EspB mutants in REPEC O103
was greatly decreased, and growth curves from rabbits in-
fected with both mutant strains were similar to a control
group. Furthermore, the infection of REPEC O103, but
not EspA and EspB mutant strains, showed histopathologi-
cal features including blunting of villi, necrosis, and inflam-
mation (Fig. 4). These results clearly indicate that both
EspA and EspB proteins are virulence factors that are
needed for these histopathological effects.
Using SEM, the initial adherence of both mutant strains
was quite similar to that of the wild-type strains (Fig. 5), in-
dicating that other adhesins such as AF/R2 fimbriae may
contribute to initial levels of adherence. In contrast, only
the wild-type strain showed formation of embedded (Fig. 5
B) and cup-like (Fig. 5 C) structures on the epithelial sur-
face. These adherent characteristics were further analyzed
by TEM. We could detect formation of the A/E lesion and
this formation only occurred in rabbits infected with the
wild-type, but not EspA and EspB mutant strains. Further-
more, pedestal-like structures (using TEM) were only seen
in the wild-type strain. These results suggest that formation
of the A/E lesion followed by pedestal-like structures re-
quired EspA and EspB. This is the first study suggesting
that EspA and EspB are needed for formation of A/E le-
sions and pedestal-like structures in an in vivo natural in-
fection model and that these processes are needed for dis-
ease.
CLSM studies showed that extensive cytoskeletal rear-
rangements beneath the attached bacteria only occurred
when rabbits were infected with wild-type, but not EspA
and EspB mutant, strains, indicating that EspA and EspB
trigger cytoskeletal rearrangements in vivo (Fig. 7) similar
to that seen in vitro. Immunostained thick sections with
phalloidin-TxR revealed that heavy cytoskeletal rearrange-
ments were composed of filamentous actin and were ob-
served as cup-like structures beneath attached bacteria.
Collectively, these results suggest that EspA and EspB are
required for cytoskeletal actin rearrangements, and A/E le-
sions followed by pedestal-like structures are formed by ac-
tin reorganization. Therefore, continued cytoskeletal rear-
rangements might contribute to disease in infected animals,
probably by disrupting the brush border.
We confirmed that REPEC O103 does not produce
Shiga toxin (STX) I and II using an enzyme-linked assay
(data not shown), since some REPEC O103 strains pro-
duce STX I or II (27, 41, 42) and this might facilitate their
virulence. Thus although RDEC O103 does not encode
STX and appears to have no invasive ability, this pathogen
still disrupted the epithelial surface, and this was correlated
to A/E lesion production.
In conclusion, we showed that EspA and EspB proteins
are required for virulence and to trigger formation of the
A/E lesion in vivo, which contains cytoskeletal actin rear-
rangements. The role of the type III secretion system and
its secreted components have been extensively studied in1915 Abe et al.
vitro using cultured epithelial cells. We have now extended
those observations to a natural infection model and con-
firmed that these events do indeed occur in vivo, and,
more importantly, are critical for disease.
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